Friedman Aviad 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 13, 2018
Insider Transaction Report
Form 4
Friedman Aviad
Director
Transactions
- Purchase
Common Stock
2018-08-09$4.82/sh+500$2,410→ 10,191 total(indirect: By wholly-owned corporation) - Purchase
Common Stock
2018-08-09$4.98/sh+2,000$9,960→ 12,191 total(indirect: By wholly-owned corporation)
Holdings
- 10,000
Common Stock